These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38335187)

  • 1. Enrichment of infection-associated bacteria in the low biomass brain bacteriota of Alzheimer's disease patients.
    Ko YK; Kim E; Lee EJ; Nam SJ; Kim Y; Kim S; Choi SY; Kim HY; Choi Y
    PLoS One; 2024; 19(2):e0296307. PubMed ID: 38335187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence supportive of a bacterial component in the etiology for Alzheimer's disease and for a temporal-spatial development of a pathogenic microbiome in the brain.
    Moné Y; Earl JP; Król JE; Ahmed A; Sen B; Ehrlich GD; Lapides JR
    Front Cell Infect Microbiol; 2023; 13():1123228. PubMed ID: 37780846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Much ado about nothing? Off-target amplification can lead to false-positive bacterial brain microbiome detection in healthy and Parkinson's disease individuals.
    Bedarf JR; Beraza N; Khazneh H; Özkurt E; Baker D; Borger V; Wüllner U; Hildebrand F
    Microbiome; 2021 Mar; 9(1):75. PubMed ID: 33771222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine particulate matter aggravates intestinal and brain injury and affects bacterial community structure of intestine and feces in Alzheimer's disease transgenic mice.
    Fu P; Bai L; Cai Z; Li R; Yung KKL
    Ecotoxicol Environ Saf; 2020 Apr; 192():110325. PubMed ID: 32078839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinflammatory Responses Occur in Brain Lesions During Alzheimer's Disease: Postmortem Case Report.
    Belkhelfa M; Bekrar S; Rezaig L; Beder N; Touri F; Yousfi Y; Nabi H; Slimani A; Attal N; Belarbi A; Bessaha M; Touil-Boukoffa C
    J Alzheimers Dis; 2024; 97(3):1323-1339. PubMed ID: 38277295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.
    Barroeta-Espar I; Weinstock LD; Perez-Nievas BG; Meltzer AC; Siao Tick Chong M; Amaral AC; Murray ME; Moulder KL; Morris JC; Cairns NJ; Parisi JE; Lowe VJ; Petersen RC; Kofler J; Ikonomovic MD; López O; Klunk WE; Mayeux RP; Frosch MP; Wood LB; Gomez-Isla T
    Neurobiol Dis; 2019 Jan; 121():327-337. PubMed ID: 30336198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
    Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer's disease brain tissue.
    Poole S; Singhrao SK; Kesavalu L; Curtis MA; Crean S
    J Alzheimers Dis; 2013; 36(4):665-77. PubMed ID: 23666172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study.
    Ramos Bernardes da Silva Filho S; Oliveira Barbosa JH; Rondinoni C; Dos Santos AC; Garrido Salmon CE; da Costa Lima NK; Ferriolli E; Moriguti JC
    Neuroimage Clin; 2017; 15():15-24. PubMed ID: 28459000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer's disease.
    Semick SA; Bharadwaj RA; Collado-Torres L; Tao R; Shin JH; Deep-Soboslay A; Weiss JR; Weinberger DR; Hyde TM; Kleinman JE; Jaffe AE; Mattay VS
    Acta Neuropathol; 2019 Apr; 137(4):557-569. PubMed ID: 30712078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of Alzheimer's disease-associated protein (ADAP) in 10 human brains.
    Miller BE; Whetsell WO; Chong JK; Ghanbari HA
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):303-7. PubMed ID: 1498582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
    Moonen S; Koper MJ; Van Schoor E; Schaeverbeke JM; Vandenberghe R; von Arnim CAF; Tousseyn T; De Strooper B; Thal DR
    Acta Neuropathol; 2023 Feb; 145(2):175-195. PubMed ID: 36481964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain.
    Emery DC; Shoemark DK; Batstone TE; Waterfall CM; Coghill JA; Cerajewska TL; Davies M; West NX; Allen SJ
    Front Aging Neurosci; 2017; 9():195. PubMed ID: 28676754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology.
    Thal DR; Schultz C; Botez G; Del Tredici K; Mrak RE; Griffin WS; Wiestler OD; Braak H; Ghebremedhin E
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):270-9. PubMed ID: 15885064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do Periodontal Pathogens or Associated Virulence Factors Have a Deleterious Effect on the Blood-Brain Barrier, Contributing to Alzheimer's Disease?
    Kouki MA; Pritchard AB; Alder JE; Crean S
    J Alzheimers Dis; 2022; 85(3):957-973. PubMed ID: 34897087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in INSR, APBA2 and IDE Gene Expressions in Brains of Alzheimer's Disease Patients.
    da Costa IB; de Labio RW; Rasmussen LT; Viani GA; Chen E; Villares J; Turecki G; Smith MAC; Payao SLM
    Curr Alzheimer Res; 2017; 14(7):760-765. PubMed ID: 28164769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer's Disease.
    Velásquez E; Szeitz B; Gil J; Rodriguez J; Palkovits M; Renner É; Hortobágyi T; Döme P; Nogueira FC; Marko-Varga G; Domont GB; Rezeli M
    Front Immunol; 2021; 12():750665. PubMed ID: 34712240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer's disease and frontotemporal lobar degeneration.
    Hok-A-Hin YS; Hoozemans JJM; Hu WT; Wouters D; Howell JC; Rábano A; van der Flier WM; Pijnenburg YAL; Teunissen CE; Del Campo M
    Alzheimers Res Ther; 2022 Jul; 14(1):100. PubMed ID: 35879733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.